SCHEMBL3561692

SCHEMBL3561692

CON(C)C(=O)c1csc(-n2ccnc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.42
HTT P42858 1/20 0.37
CYP3A4 P08684 5/20 0.36
CYP2D6 P10635 5/20 0.36
CYP1A2 P05177 4/20 0.36
CLK4 Q9HAZ1 4/20 0.36
CYP2C19 P33261 4/20 0.36
ALOX15 P16050 3/20 0.36
HSD17B10 Q99714 3/20 0.36
APEX1 P27695 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP11B1 P15538 2/20 0.35
CYP11B2 P19099 2/20 0.35
BAZ2B Q9UIF8 1/20 0.34
CYP19A1 P11511 1/20 0.34
MAPK8 P45983 1/20 0.34
MAPK10 P53779 1/20 0.34
LMNA P02545 2/20 0.33
TP53 P04637 1/20 0.33
CD38 P28907 6/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31216581 0.81 HTT (0.50) CHEK1HTTCYP3A4CYP2D6CYP2C19
SCHEMBL3563236 0.79 CHEK1 (0.47) CHEK1HTTCYP3A4BAZ2BLMNA
SCHEMBL31216537 0.78 CHEK1 (0.48) CHEK1CYP1A2CYP2C19
SCHEMBL5868906 0.75 RAB9A (0.51) CHEK1CYP1A2CYP2C19LMNAMAPT
SCHEMBL3561688 0.75 CHEK1 (0.48) CHEK1HTTCYP3A4CYP2D6CYP1A2
SCHEMBL3558152 0.73 CD38 (0.40) HTTCYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL21912296 0.72 ALDH1A1 (0.45) CHEK1HTTCYP2D6CYP1A2CYP2C19
SCHEMBL13598494 0.71 TLR7 (0.41) HTTMAPK1MAPT
SCHEMBL3569043 0.71 CLK1 (0.37) MAPK1MAPT
SCHEMBL5868797 0.71 CHEK1 (0.44) CHEK1HTTCYP3A4BAZ2BMAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825256-B2 Inducible nitric oxide synthase dimerization inhibitors KALYPSYS, INC. (US) 2010-11-02 US disclosed
US-7825256-B2 Inducible nitric oxide synthase dimerization inhibitors KALYPSYS, INC. (US) 2010-11-02 US disclosed
US-7825256-B2 Inducible nitric oxide synthase dimerization inhibitors KALYPSYS, INC. (US) 2010-11-02 US disclosed
US-20060116515-A1 Inducible nitric oxide synthase dimerization inhibitors KALYPSYS, INC. 2006-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060116515-A1 Inducible nitric oxide synthase dimerization inhibitors NOS3, NOS2, NOS1 CHEK1 4415/4885HTT 4845/4885CYP3A4 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.